C

Cascara Ventures

1 employees

Cascara invests in the seed stage of companies that apply technology to prevention, therapy and research.

Investor insights

Sectors invested in

Health Care7
Biotechnology6
Medical Device6
Medical5
knee2
meniscus2
meniscus prosthesis2
osteoarthritis2
medtech2
orthopaedics2
Emergency Medicine2
Software2
Productivity Tools2
Navigation2
Digital Health2
Training2
Pathology2
Data Curation2
Clinical Study Publishing2
Digital Pathology2

Funding rounds participated in

$2M sweet spot round size

Most of their 12 investments are in rounds between $1.2M and $2M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Allergy
Immune Therapy
Health Economics
Stroke
Interventional Cardiology
Oncology
Pharmaceutical Medicine
Orthopedic Surgery
Neurosurgery
Surgical Navigation
Neurology
Pain
Surgery
Heart Failure
Diabetes
Cardiology
Venture Capital

Date founded

2016

Investments made

A

ATRO Medical BV raised $2.1M on December 14, 2021

Investors: Innovatiefonds Noord-Holland, Oost NL, Thuja Capital, DSM Venturing and Cascara Ventures

S

Surgify Medical Oy raised $1.2M on October 25, 2017

Investors: Butterfly Ventures and Cascara Ventures

A

ATRO Medical BV raised undisclosed on July 17, 2017

Investors: Thuja Capital, BOM (Brabantse Ontwikkelings Maatschappij), Radboudumc, DSM Venturing and Cascara Ventures

D

Desentum Oy raised $2M on January 23, 2017

Investors: - and Cascara Ventures

m

microDimensions raised undisclosed on June 16, 2016

Investors: Bayern Kapital GmbH and Cascara Ventures

x

xbird GmbH raised undisclosed on January 1, 2016

Investors: Cascara Ventures

P

Preventicus GmbH raised undisclosed on January 1, 2016

Investors: Cascara Ventures

F

Fiagon raised undisclosed on December 31, 2015

Investors: Cascara Ventures

m

microDimensions raised undisclosed on February 27, 2014

Investors: High-Tech Gründerfonds, Bayern Kapital GmbH and Cascara Ventures

F

Fiagon raised undisclosed on November 20, 2012

Investors: Cascara Ventures

FAQ